We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CLPBY market cap is 26.97B. The company's latest EPS is DKK 2.2755 and P/E is 56.18.
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 17.94B | 18.54B | 19.43B | 22.58B | 24.5B |
| Operating Income | 5.16B | 5.85B | 6.16B | 6.44B | 6.77B |
| Net Income | 3.87B | 4.2B | 4.83B | 4.71B | 4.78B |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 12.73B | 13.5B | 15.84B | 34.96B | 48.16B |
| Total Liabilities | 5.82B | 6.09B | 7.67B | 26.66B | 30.86B |
| Total Equity | 6.91B | 7.41B | 8.17B | 8.29B | 17.3B |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 4.36B | 4.76B | 5.29B | 5.1B | 4.23B |
| Investing | -591M | -901M | -2.01B | -11.76B | -8.96B |
| Financing | -3.71B | -3.86B | -3.18B | 6.59B | 5.27B |
| Market Cap | 26.97B |
| Price to Earnings Ratio | 56.18 |
| Price to Sales Ratio | 10.97 |
| Price to Cash Ratio | 294.95 |
| Price to Book Ratio | 15.53 |
| Dividend Yield | 1.52% |
| Shares Outstanding | 2.1B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (0.31%) |
| Company Name | Coloplast AS (PK) |
| Address |
holtedam 1-3 humlebaek DK-3050 |
| Website | https://www.coloplast.com |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
